People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Biotechnology, Other, Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ivenix, Inc. | — | Biotechnology | Series B | $82.9M | $396.9M | 2009 |
| Awarepoint Corp | — | Other | Series B | $79.2M | $8.3M | 2009 |
| MDx Medical, Inc. - NJ | — | Other Technology | Series B | $38.9M | $597.1M | 2011 |
| Cureatr Inc. | — | Other Technology | Series A | $28.6M | $25.1M | 2013 |
| Coderyte Inc | — | Other Health Care | Seed | $2.5M | $62.0M | 2011 |
Brandon Hull at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brandon Hull on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Todd Pietri | 2 | 13 |
| John Clarke | 2 | 8 |
| Bryan Roberts | 1 | 18 |
| William Sullivan | 1 | 13 |
| Brian Ascher | 1 | 11 |
| Ketan Patel | 1 | 10 |
| Vijay Lathi | 1 | 8 |
| Dana Mead | 1 | 7 |
| Wei Li | 1 | 7 |
| Tom Mawhinney | 1 | 6 |
| James Bradley | 1 | 6 |
| JOHN GANNON | 1 | 6 |
| John K. Clarke | 1 | 5 |
| Wayne B. Weisman | 1 | 5 |
| Thomas Mawhinney | 1 | 5 |
| Edward Zander | 1 | 4 |
| John Wu | 1 | 4 |
| Henry Newman | 1 | 3 |
| Richard Toren | 1 | 3 |
| Andrew Eckert | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.